Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Conmed (CNMD) Interest Expenses (2016 - 2025)

Conmed's Interest Expenses history spans 16 years, with the latest figure at $7.6 million for Q3 2025.

  • For Q3 2025, Interest Expenses fell 17.79% year-over-year to $7.6 million; the TTM value through Dec 2025 reached $23.7 million, up 347.2%, while the annual FY2025 figure was $418000.0, N/A changed from the prior year.
  • Interest Expenses reached $7.6 million in Q3 2025 per CNMD's latest filing, down from $7.8 million in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $10.4 million in Q1 2021 to a low of -$28.4 million in Q4 2024.
  • Average Interest Expenses over 5 years is $5.6 million, with a median of $8.3 million recorded in 2025.
  • Peak YoY movement for Interest Expenses: surged 123.23% in 2021, then crashed 399.24% in 2024.
  • A 5-year view of Interest Expenses shows it stood at $7.6 million in 2021, then dropped by 21.67% to $5.9 million in 2022, then skyrocketed by 60.32% to $9.5 million in 2023, then plummeted by 399.24% to -$28.4 million in 2024, then soared by 126.74% to $7.6 million in 2025.
  • Per Business Quant, the three most recent readings for CNMD's Interest Expenses are $7.6 million (Q3 2025), $7.8 million (Q2 2025), and $8.3 million (Q1 2025).